Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector

Guide for the Care and Use of Laboratory Animals: Eighth Edition

(2011) · doi:10.17226/12910 · Cited by 16,199 · see citing works

Retinitis pigmentosa

Hartong, D. T., Berson, E. L., & Dryja, T. P. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69740-7 · Cited by 2,924 · see citing works

Gene therapy comes of age

Dunbar, C. E., High, K. A., Joung, J. K., Kohn, D. B., Ozawa, K., & Sadelain, M. (2018) · Science · doi:10.1126/science.aan4672 · Cited by 1,410 · see citing works

Gene therapy clinical trials worldwide to 2012 – an update

Ginn, S., Alexander, I. E., Edelstein, M. L., Abedi, M. R., & Wixon, J. (2013) · Journal of Gene Medicine · doi:10.1002/jgm.2698 · Cited by 807 · see citing works

Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis

McCarty, D., Monahan, P., & Samulski, R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301514 · Cited by 735 · see citing works

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study

Miller, T. M., Pestronk, A., David, W., Rothstein, J., Simpson, E., Appel, S. H., Andres, P. L., Mahoney, K., Allred, P., Alexander, K., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70061-9 · Cited by 617 · see citing works

A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells

Zolotukhin, S., Potter, M., Hauswirth, W. W., Guy, J., & Muzyczka, N. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4646-4654.1996 · Cited by 609 · see citing works

Tissue-Specific Differences in Human Transfer RNA Expression

Dittmar, K. A., Goodenbour, J. M., & Pan, T. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020221 · Cited by 601 · see citing works

Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors

Zolotukhin, S., Potter, M., Zolotukhin, I., Sakai, Y., Loiler, S., Fraites, T. J., Chiodo, V. A., Philipsberg, T., Muzyczka, N., Hauswirth, W. W., et al. (2002) · Methods · doi:10.1016/s1046-2023(02)00220-7 · Cited by 556 · see citing works

Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo

McCarty, D. M., Fu, H., Monahan, P. E., Toulson, C. E., Naik, P., & Samulski, R. J. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302134 · Cited by 547 · see citing works

Rhodopsin mutations in autosomal dominant retinitis pigmentosa.

Sung, C.-H., Davenport, C., Hennessey, J. C., Maumenee, I. H., Jacobson, S. G., Heckenlively, J. R., NOWAKOWSKI, R. W., Fishman, G. A., Gouras, P., & Nathans, J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6481 · Cited by 462 · see citing works

Transgenic mice with a rhodopsin mutation (Pro23His): A mouse model of autosomal dominant retinitis pigmentosa

Olsson, J. E., Gordon, J. W., Pawlyk, B. S., Roof, D., Hayes, A., Molday, R. S., Mukai, S., Cowley, G. S., Berson, E. L., & Dryja, T. P. (1992) · Neuron · doi:10.1016/0896-6273(92)90236-7 · Cited by 455 · see citing works

Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa

Lewin, A. S., Drenser, K. A., Hauswirth, W. W., Nishikawa, S., Yasumura, D., Flannery, J. G., & LaVail, M. M. (1998) · Nature Medicine · doi:10.1038/nm0898-967 · Cited by 405 · see citing works

Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model

Auricchio, A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.26.3075 · Cited by 394 · see citing works

The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy

Athanasiou, D., Aguilà, M., Bellingham, J., Li, W., McCulley, C. H., Reeves, P. J., & Cheetham, M. E. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.002 · Cited by 368 · see citing works

Rhodopsin mutations responsible for autosomal dominant retinitis pigmentosa. Clustering of functional classes along the polypeptide chain.

Sung, C.-H., Davenport, C., & Nathans, J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74360-9 · Cited by 334 · see citing works

In Vivo CRISPR/Cas9 Gene Editing Corrects Retinal Dystrophy in the S334ter-3 Rat Model of Autosomal Dominant Retinitis Pigmentosa

Bakondi, B., Lv, W., Lü, B., Jones, M. K., Tsai, Y.-C., Kim, K. J., Levy, R., Akhtar, A. A., Breunig, J. J., Svendsen, C. N., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.220 · Cited by 300 · see citing works

Prevalence of Disease-Causing Mutations in Families with Autosomal Dominant Retinitis Pigmentosa: A Screen of Known Genes in 200 Families

Sullivan, L. S., Bowne, S. J., Birch, D. G., Hughbanks-Wheaton, D. K., Heckenlively, J. R., Lewis, R. A., GARCIA, C. A., Ruiz, R. S., Blanton, S. H., Northrup, H., et al. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1443 · Cited by 285 · see citing works

Probing Mechanisms of Photoreceptor Degeneration in a New Mouse Model of the Common Form of Autosomal Dominant Retinitis Pigmentosa due to P23H Opsin Mutations

Sakami, S., Maeda, T., Bereta, G. P., Okano, K., Golczak, M., Sumaroka, A., Román, A. J., Cideciyan, A. V., Jacobson, S. G., & Palczewski, K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.209759 · Cited by 283 · see citing works

Disease sequence from mutant rhodopsin allele to rod and cone photoreceptor degeneration in man

Cideciyan, A. V., Hood, D. C., Huang, Y., Banin, E., Li, Z., Stone, E. M., Milam, A. H., & Jacobson, S. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.7103 · Cited by 278 · see citing works

Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa

Beltran, W. A., Cideciyan, A. V., Lewin, A. S., Iwabe, S., Khanna, H., Sumaroka, A., Chiodo, V. A., Fajardo, D. S., Román, A. J., Deng, W.-T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118847109 · Cited by 260 · see citing works

Clinical development of gene therapy: results and lessons from recent successes

Kumar, S. R. P., Markusic, D. M., Biswas, M., High, K. A., & Herzog, R. W. (2016) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2016.34 · Cited by 235 · see citing works

Autosomal Dominant Sectoral Retinitis Pigmentosa

Heckenlively, J. R. (1991) · Archives of Ophthalmology · doi:10.1001/archopht.1991.01080010086038 · Cited by 221 · see citing works

Measurement of average decoding rates of the 61 sense codons in vivo

Gardin, J., Yeasmin, R., Yurovsky, A., Cai, Y., Skiena, S., & Futcher, B. (2014) · eLife · doi:10.7554/elife.03735 · Cited by 208 · see citing works

Ribozyme rescue of photoreceptor cells in P23H transgenic rats: Long-term survival and late-stage therapy

LaVail, M. M., Yasumura, D., Matthes, M. T., Drenser, K. A., Flannery, J. G., Lewin, A. S., & Hauswirth, W. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210319397 · Cited by 203 · see citing works

In vivo dynamics of retinal injury and repair in the rhodopsin mutant dog model of human retinitis pigmentosa

Cideciyan, A. V., Jacobson, S. G., Alemán, T. S., Gu, D., Pearce-Kelling, S. E., Sumaroka, A., Acland, G. M., & Aguirre, G. K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408892102 · Cited by 187 · see citing works

RNA Interference–Mediated Suppression and Replacement of Human Rhodopsin In Vivo

O’Reilly, M., Palfi, A., Chadderton, N., Millington‐Ward, S., Ader, M., Cronin, T., Tuohy, T., Auricchio, A., Hildinger, M., Tivnan, A., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519025 · Cited by 173 · see citing works

In vivo Editing of the Human Mutant Rhodopsin Gene by Electroporation of Plasmid-based CRISPR/Cas9 in the Mouse Retina

Latella, M. C., Salvo, M. T. D., Cocchiarella, F., Benati, D., Grisendi, G., Comitato, A., Marigo, V., & Recchia, A. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.92 · Cited by 166 · see citing works

Retinal Function and Rhodopsin Levels in Autosomal Dominant Retinitis Pigmentosa With Rhodopsin Mutations

Jacobson, S. G., Kemp, C. M., Sung, C.-H., & Nathans, J. (1991) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)76726-1 · Cited by 164 · see citing works

Naturally occurring rhodopsin mutation in the dog causes retinal dysfunction and degeneration mimicking human dominant retinitis pigmentosa

Kijas, J., Cideciyan, A. V., Alemán, T. S., Pianta, M. J., Pearce-Kelling, S. E., Miller, B. J., Jacobson, S. G., Aguirre, G. K., & Acland, G. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082714499 · Cited by 163 · see citing works

The relationship between opsin overexpression and photoreceptor degeneration.

Tan, E., Wang, Q., Quiambao, A. B., Xu, X., Qtaishat, N. M., Peachey, N. S., Lem, J., Fliesler, S. J., Pepperberg, D. R., Naash, M. I., et al. (2001) · PubMed · Cited by 161 · see citing works

A completed screen for mutations of the rhodopsin gene in a panel of patients with autosomal dominant retinitis piamentosa

Inglehearn, C. F., Keen, T. J., Bashir, R., et al. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.1.41 · Cited by 153 · see citing works

Light and inherited retinal degeneration

Paskowitz, D. M. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.097436 · Cited by 151 · see citing works

An unusually compact external promoter for RNA polymerase III transcription of the human H1RNA gene

Myslinski, E. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.12.2502 · Cited by 148 · see citing works

Using CRISPR-Cas9 to Generate Gene-Corrected Autologous iPSCs for the Treatment of Inherited Retinal Degeneration

Burnight, E. R., Gupta, M., Wiley, L. A., Anfinson, K. R., Tran, A. A., Triboulet, R., Hoffmann, J. M., Klaahsen, D., Andorf, J. L., Jiao, C., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.05.015 · Cited by 144 · see citing works

Suppression and Replacement Gene Therapy for Autosomal Dominant Disease in a Murine Model of Dominant Retinitis Pigmentosa

Millington‐Ward, S., Chadderton, N., O’Reilly, M., Palfi, A., Goldmann, T., Kilty, C., Humphries, M. M., Wolfrum, U., Bennett, J., Humphries, P., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.293 · Cited by 141 · see citing works

Canine Retina Has a Primate Fovea-Like Bouquet of Cone Photoreceptors Which Is Affected by Inherited Macular Degenerations

Beltran, W. A., Cideciyan, A. V., Guziewicz, K. E., Iwabe, S., Świder, M., Scott, E. M., Savina, S. V., Ruthel, G. T., Stefano, F. P., Zhang, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090390 · Cited by 128 · see citing works

Improved Retinal Function in a Mouse Model of Dominant Retinitis Pigmentosa Following AAV-delivered Gene Therapy

Chadderton, N., Millington‐Ward, S., Palfi, A., O’Reilly, M., Tuohy, G., Humphries, M. M., Li, T., Humphries, P., Kenna, P. F., & Farrar, G. J. (2009) · Molecular Therapy · doi:10.1038/mt.2008.301 · Cited by 123 · see citing works

Sustained miRNA-mediated Knockdown of Mutant AAT With Simultaneous Augmentation of Wild-type AAT Has Minimal Effect on Global Liver miRNA Profiles

Mueller, C., Tang, Q., Gruntman, A. M., Blomenkamp, K., Teckman, J. H., Song, L., Zamore, P. D., & Flotte, T. R. (2012) · Molecular Therapy · doi:10.1038/mt.2011.292 · Cited by 117 · see citing works

AAV Delivery of Wild-Type Rhodopsin Preserves Retinal Function in a Mouse Model of Autosomal Dominant Retinitis Pigmentosa

Mao, H., Thomas, J., Schwein, A., Shabashvili, A. E., Hauswirth, W. W., Gorbatyuk, M. S., & Lewin, A. S. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.140 · Cited by 114 · see citing works

P23H opsin knock-in mice reveal a novel step in retinal rod disc morphogenesis

Sakami, S., Kolesnikov, A. V., Kefalov, V. J., & Palczewski, K. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt561 · Cited by 110 · see citing works

Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward

Bennett, J. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.008 · Cited by 110 · see citing works

Twenty-Five Years of Gene Therapy for ADA-SCID: From Bubble Babies to an Approved Drug

Ferrua, F., & Aiuti, A. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.175 · Cited by 104 · see citing works

Phenotypes of stop codon and splice site rhodopsin mutations causing retinitis pigmentosa.

Jacobson, S. G., Kemp, C. M., Cideciyan, A. V., Macke, J. P., Sung, C.-H., & Nathans, J. (1994) · PubMed · Cited by 103 · see citing works

Allele-Specific Inhibition of Rhodopsin With an Antisense Oligonucleotide Slows Photoreceptor Cell Degeneration

Murray, S., Jazayeri, A., Matthes, M. T., Yasumura, D., Yang, H., Peralta, R. Q., Watt, A., Freier, S., Hung, G., Adamson, P., et al. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16400 · Cited by 103 · see citing works

rAAV2/5 gene-targeting to rods:dose-dependent efficiency and complications associated with different promoters

Beltran, W. A., Boye, S. L., Boye, S. E., Chiodo, V. A., Lewin, A. S., Hauswirth, W. W., & Aguirre, G. D. (2010) · Gene Therapy · doi:10.1038/gt.2010.56 · Cited by 96 · see citing works

Retinitis pigmentosa associated with rhodopsin mutations: Correlation between phenotypic variability and molecular effects

Iannaccone, A., Man, D., Waseem, N. H., Jennings, B., Ganapathiraju, M. K., Gallaher, K. T., Reese, E., Bhattacharya, S. S., & Klein‐Seetharaman, J. (2006) · Vision Research · doi:10.1016/j.visres.2006.08.018 · Cited by 92 · see citing works

Successful arrest of photoreceptor and vision loss expands the therapeutic window of retinal gene therapy to later stages of disease

Beltran, W. A., Cideciyan, A. V., Iwabe, S., Świder, M., Kosyk, M. S., McDaid, K. S., Martynyuk, I., Ying, G., Shaffer, J., Deng, W., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509914112 · Cited by 90 · see citing works

The Role of Rhodopsin Glycosylation in Protein Folding, Trafficking, and Light-Sensitive Retinal Degeneration

Tam, B. M., & Moritz, O. L. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4259-09.2009 · Cited by 88 · see citing works

Strategems in vitro for gene therapies directed to dominant mutations

Millington‐Ward, S. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.9.1415 · Cited by 88 · see citing works

Toward a Gene Therapy for Dominant Disease: Validation of an RNA Interference-Based Mutation-Independent Approach

Kiang, A., Palfi, A., Ader, M., Kenna, P. F., Millington‐Ward, S., Clark, G., Kennan, A., O’Reilly, M., Tam, L. C. S., Aherne, A., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.028 · Cited by 83 · see citing works

Transient Photoreceptor Deconstruction by CNTF Enhances rAAV-Mediated Cone Functional Rescue in Late Stage CNGB3-Achromatopsia

Komáromy, A. M., Rowlan, J. S., Corr, A. T. P., Reinstein, S. L., Boye, S. L., Cooper, A. E., Gonzalez, A., Levy, B. J., Wen, R., Hauswirth, W. W., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.50 · Cited by 82 · see citing works

Preservation of photoreceptor morphology and function in P23H rats using an allele independent ribozyme

Gorbatyuk, M. S., Justilien, V., Liu, J., Hauswirth, W. W., & Lewin, A. S. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.08.014 · Cited by 82 · see citing works

ER Stress Is Involved in T17M Rhodopsin-Induced Retinal Degeneration

Kunte, M. M., Choudhury, S., Manheim, J. F., Shinde, V. M., Miura, M., Chiodo, V. A., Hauswirth, W. W., Gorbatyuk, O. S., & Gorbatyuk, M. S. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-9235 · Cited by 82 · see citing works

Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations

Beltran, W. A., Cideciyan, A. V., Boye, S. E., Ye, G.-J., Iwabe, S., Dufour, V. L., Marinho, L. F., Swider, M., Kosyk, M. S., Sha, J., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.05.004 · Cited by 82 · see citing works

Ribozyme-targeted destruction of RNA associated with autosomal-dominant retinitis pigmentosa.

Drenser, K. A., Timmers, A. M., Hauswirth, W. W., & Lewin, A. S. (1998) · PubMed · Cited by 81 · see citing works

BEST1 gene therapy corrects a diffuse retina-wide microdetachment modulated by light exposure

Guziewicz, K. E., Cideciyan, A. V., Beltran, W. A., Komáromy, A. M., Dufour, V., Świder, M., Iwabe, S., Sumaroka, A., Kendrick, B. T., Ruthel, G. T., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720662115 · Cited by 80 · see citing works

Long-Term Rescue of Retinal Structure and Function by Rhodopsin RNA Replacement with a Single Adeno-Associated Viral Vector in P23H RHO Transgenic Mice

Mao, H., Gorbatyuk, M. S., Rossmiller, B. P., Hauswirth, W. W., & Lewin, A. S. (2012) · Human Gene Therapy · doi:10.1089/hum.2011.213 · Cited by 79 · see citing works

Prevalence of Mutations in eyeGENE Probands With a Diagnosis of Autosomal Dominant Retinitis Pigmentosa

Sullivan, L. S., Bowne, S. J., Reeves, M. J., et al. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12605 · Cited by 78 · see citing works

Zinc‐finger‐based transcriptional repression of rhodopsin in a model of dominant retinitis pigmentosa

Mussolino, C., Sanges, D., Marrocco, E., Bonetti, C., Vicino, U. D., Marigo, V., Auricchio, A., Meroni, G., & Surace, E. M. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201000119 · Cited by 73 · see citing works

Rhodopsin Mutant P23H Destabilizes Rod Photoreceptor Disk Membranes

Haeri, M., & Knox, B. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030101 · Cited by 69 · see citing works

A Naturally Occurring Mutation of the Opsin Gene (T4R) in Dogs Affects Glycosylation and Stability of the G Protein-coupled Receptor

Zhu, L. H., Jang, G.-F., Jastrzębska, B., Filipek, S., Pearce-Kelling, S. E., Aguirre, G. K., Stenkamp, R. E., Acland, G. M., & Palczewski, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408472200 · Cited by 67 · see citing works

Increased Sensitivity to Light-Induced Damage in a Mouse Model of Autosomal Dominant Retinal Disease

White, D. A., Hauswirth, W. W., Kaushal, S., & Lewin, A. S. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1131 · Cited by 64 · see citing works

Suppression of mouse rhodopsin expression in vivo by AAV mediated siRNA delivery

Gorbatyuk, M. S., Justilien, V., Liu, J., Hauswirth, W. W., & Lewin, A. S. (2007) · Vision Research · doi:10.1016/j.visres.2006.11.026 · Cited by 63 · see citing works

Gene Therapy for PRPH2-Associated Ocular Disease: Challenges and ProspectsPreprint

Conley, S. M., & Naash, M. I. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017376 · Cited by 50 · see citing works

RNAi-based suppression and replacement ofrds-peripherin in retinal organotypic culture

Palfi, A., Ader, M., Kiang, A., et al. (2006) · Human Mutation · doi:10.1002/humu.20287 · Cited by 49 · see citing works

Knockdown of wild-type mouse rhodopsin using an AAV vectored ribozyme as part of an RNA replacement approach.

Gorbatyuk, M. S., Pang, J., Thomas, J., Hauswirth, W. W., & Lewin, A. S. (2005) · PubMed · Cited by 49 · see citing works

Rhodopsin targeted transcriptional silencing by DNA-binding

Botta, S., Marrocco, E., de Prisco, N., Curion, F., Renda, M., Sofia, M., Lupo, M., Carissimo, A., Bacci, M. L., Gesualdo, C., et al. (2016) · eLife · doi:10.7554/elife.12242 · Cited by 45 · see citing works

Ribozyme-based therapeutic approaches for autosomal dominant retinitis pigmentosa.

O’Neill, B., Millington‐Ward, S., O’Reilly, M., et al. (2000) · PubMed · Cited by 44 · see citing works

Preferential silencing of a common dominant rhodopsin mutation does not inhibit retinal degeneration in a transgenic model

Tessitore, A., Parisi, F., Denti, M. A., Allocca, M., Vicino, U. D., Domenici, L., Bozzoni, I., & Auricchio, A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.07.008 · Cited by 40 · see citing works

Novel pathogenic mutations in C1QTNF5 support a dominant negative disease mechanism in late-onset retinal degeneration

Stanton, C. M., Borooah, S., Drake, C., Marsh, J. A., Campbell, S. E., Lennon, A., Soares, D. C., Vallabh, N. A., Sahni, J., Cideciyan, A. V., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11898-3 · Cited by 40 · see citing works

Gene Therapy for Autosomal Dominant Disorders of Keratin

Lewin, A. S., Glazer, P. M., & Milstone, L. M. (2005) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1111/j.1087-0024.2005.10207.x · Cited by 37 · see citing works

Complexity of the Class B Phenotype in Autosomal Dominant Retinitis Pigmentosa Due to Rhodopsin Mutations

Jacobson, S. G., McGuigan, D. B., Sumaroka, A., Román, A. J., Gruzensky, M. L., Sheplock, R., Palma, J., Schwartz, S., Alemán, T. S., & Cideciyan, A. V. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19890 · Cited by 37 · see citing works

Hammerhead ribozymes designed to cleave all human rod opsin mRNAs which cause autosomal dominant retinitis pigmentosa.

Sullivan, J. M., Pietras, K. M., Shin, B. J., et al. (2002) · PubMed · Cited by 33 · see citing works

Assessment of visual function and retinal structure following acute light exposure in the light sensitive T4R rhodopsin mutant dog

Iwabe, S., Ying, G., Aguirre, G. D., & Beltran, W. A. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.04.006 · Cited by 33 · see citing works

Simple and efficient DNA vector-based RNAi systems in mammalian cells

Wu, M.-T., Wu, R., Hung, C., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.129 · Cited by 32 · see citing works

An allele-specific hammerhead ribozyme gene therapy for a porcine model of autosomal dominant retinitis pigmentosa.

Shaw, L. C., Skold, A., Wong, F., et al. (2001) · PubMed · Cited by 30 · see citing works

Therapy for Dominant Inherited Diseases by Allele-Specific RNA Interference: Successes and Pitfalls

Trochet, D., Prudhon, B., Vassilopoulos, S., & Bitoun, M. (2015) · Current Gene Therapy · doi:10.2174/1566523215666150812115730 · Cited by 27 · see citing works

Clinical Light Exposure, Photoreceptor Degeneration, and AP-1 Activation: A Cell Death or Cell Survival Signal in the Rhodopsin Mutant Retina?

Gu, D., Beltran, W. A., Li, Z., Acland, G. M., & Aguirre, G. K. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0428 · Cited by 25 · see citing works

A transgenic mouse model for gene therapy of rhodopsin-linked Retinitis Pigmentosa

O’Reilly, M., Millington‐Ward, S., Palfi, A., et al. (2007) · Vision Research · doi:10.1016/j.visres.2007.08.014 · Cited by 24 · see citing works

Exclusion of the Unfolded Protein Response in Light-Induced Retinal Degeneration in the Canine T4R RHO Model of Autosomal Dominant Retinitis Pigmentosa

Marsili, S., Genini, S., Sudharsan, R., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115723 · Cited by 21 · see citing works

Acute and Protracted Cell Death in Light-Induced Retinal Degeneration in the Canine Model of Rhodopsin Autosomal Dominant Retinitis Pigmentosa

Sudharsan, R., Simone, K. M., Anderson, N. P., et al. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20749 · Cited by 20 · see citing works

RNA Based Gene Therapy for Dominantly Inherited Diseases

Pelletier, R., Caron, S., & Puymirat, J. (2006) · Current Gene Therapy · doi:10.2174/156652306775515592 · Cited by 19 · see citing works

Development of lead hammerhead ribozyme candidates against human rod opsin mRNA for retinal degeneration therapy

Abdelmaksoud, H. E., Yau, E. H., Zuker, M., & Sullivan, J. M. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.11.018 · Cited by 14 · see citing works

Operating in the Dark

Komáromy, A. M. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.5.714 · Cited by 13 · see citing works

Structural Organization and Expression Pattern of the CanineRPGRIP1Isoforms in Retinal Tissue

Kuznetsova, T., Zangerl, B., Goldstein, O., et al. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6094 · Cited by 12 · see citing works

Current clinical applications of in vivo gene therapy with AAVs

Mendell, J. R., Al-Zaidy, S. A., Rodino-Klapac, L. R., Goodspeed, K., Gray, S. J., Kay, C. N., Boye, S. L., Boye, S. E., George, L. A., Salabarria, S., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.007 · Cited by 743 · see citing works

Early and late stage gene therapy interventions for inherited retinal degenerations

Botto, C., Rucli, M., Tekinsoy, M. D., Pulman, J., Sahel, J.-A., & Dalkara, D. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100975 · Cited by 190 · see citing works

Suprachoroidal and Subretinal Injections of AAV Using Transscleral Microneedles for Retinal Gene Delivery in Nonhuman Primates

Yiu, G., Chung, S. H., Mollhoff, I. N., Nguyen, U. T., Thomasy, S. M., Yoo, J., Taraborelli, D., & Noronha, G. (2020) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2020.01.002 · Cited by 153 · see citing works

Long-term Structural Outcomes of Late-stage RPE65 Gene Therapy

Gardiner, K. L., Cideciyan, A. V., Swider, M., Dufour, V. L., Sumaroka, A., Komáromy, A. M., Hauswirth, W. W., Iwabe, S., Jacobson, S. G., Beltran, W. A., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2019.08.013 · Cited by 67 · see citing works

Inflammation in Viral Vector-Mediated Ocular Gene Therapy: A Review and Report From a Workshop Hosted by the Foundation Fighting Blindness, 9/2020

Chan, Y. K., Dick, A. D., Hall, S. M., Langmann, T., Scribner, C. L., Mansfield, B. C., & for the Ocular Gene Therapy Inflammation Working Group (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.4.3 · Cited by 56 · see citing works

Engineered Capsids for Efficient Gene Delivery to the Retina and Cornea

Frederick, A., Sullivan, J., Liu, L., Adamowicz, M., Lukason, M., Raymer, J., Luo, Z., Jin, X., Rao, K. N., & O'Riordan, C. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.070 · Cited by 35 · see citing works

Gene Therapy for Inherited Retinal Degeneration

Arbabi, A., Liu, A., & Ameri, H. (2019) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2018.0087 · Cited by 30 · see citing works

Advancements in ocular gene therapy delivery: vectors and subretinal, intravitreal, and suprachoroidal techniques

Kovacs, K. D., Ciulla, T. A., & Kiss, S. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2121646 · Cited by 20 · see citing works

Correcting visual loss by genetics and prosthetics

Xue, K., & MacLaren, R. E. (2020) · Current Opinion in Physiology · doi:10.1016/j.cophys.2020.03.003 · Cited by 5 · see citing works

The Mechanism of Rhodopsin and RPE65 Protein in Light-induced Retina Degeneration

Chen, P., Liang, J., & Huan-wen, Q. (2007) · Jiguang shengwu xuebao

Rpe65 as a modifier gene for inherited retinal degeneration

Samardzija, M., Wenzel, A., Naash, M. I., Remé, C. E., & Grimm, C. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04639.x · Cited by 66 · see citing works

Rhodopsin activation causes retinal degeneration in drosophila rdgC mutant

Steele, F. R., & O’Tousa, J. E. (1990) · Neuron · doi:10.1016/0896-6273(90)90141-2 · Cited by 88 · see citing works

Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement

Cideciyan, A. V., Jacobson, S. G., Beltran, W. A., Sumaroka, A., Świder, M., Iwabe, S., Román, A. J., Olivares, M. B., Schwartz, S., Komáromy, A. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218933110 · Cited by 441 · see citing works

Endoplasmic Reticulum Stress in Vertebrate Mutant Rhodopsin Models of Retinal Degeneration

Kroeger, H., LaVail, M. M., & Lin, J. H. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3209-8_74 · Cited by 15 · see citing works